Core Insights - AMN Healthcare Services, Inc. reported adjusted earnings per share (EPS) of 39 cents for Q3 2025, a decline of 36.1% year over year, but exceeded the Zacks Consensus Estimate by 105.3% [1] - The company's revenues for the third quarter were $634.5 million, down 7.7% year over year, yet surpassed the Zacks Consensus Estimate by 3.2% [2][9] - AMN Healthcare's gross profit fell 13.4% year over year to $184.4 million, with a gross margin contraction of 193 basis points to 29.1% [7][9] Revenue Breakdown - The Nurse and Allied Solutions segment generated revenues of $361.5 million, down 9.5% year over year, with travel nurse staffing revenues declining by 20% [4] - The Physician and Leadership Solutions segment reported revenues of $178.2 million, a decrease of 1.3% year over year, while locum tenens revenues increased by 3% to $146 million [5] - The Technology and Workforce Solutions segment's revenues totaled $94.8 million, down 11.8% year over year, with a significant 32% decline in vendor management systems revenue [6] Margin Analysis - AMN Healthcare's adjusted operating profit for the quarter was $45.8 million, reflecting a 27.7% decline from the prior year, with an adjusted operating margin contraction of 200 basis points to 7.2% [7][9] - Selling, general & administrative expenses decreased by 7.4% year over year to $138.6 million [7] Financial Position - At the end of Q3 2025, AMN Healthcare had cash and cash equivalents of $52.6 million, up from $41.5 million at the end of Q2 2025, while total debt decreased to $850 million from $920 million [10] - Cumulative net cash provided by operating activities was $193.9 million, down from $247.6 million a year ago [10] Future Guidance - For Q4 2025, AMN Healthcare expects revenues in the range of $715 million to $730 million, indicating a decline of 1-3% compared to the prior year [11] - The company anticipates a 1-3% increase in revenues for the Nurse and Allied Solutions segment, while expecting a 14-16% decline in the Technology and Workforce Solutions segment [12] Overall Assessment - The overall top-line performance in Q3 2025 was disappointing, with declines across all segments and margin pressures [13] - However, there were positive indicators such as an increase in Allied revenues and expectations for strong sequential volume growth in travel nursing for Q4 [14]

Q3 2025 Financial Performance - Revenue for Q3 2025 was $634.5 million, compared to $687.5 million in Q3 2024, a decrease of 7.7%[9] - Gross profit for Q3 2025 was $184.4 million, with a gross margin of 29.1%, compared to $213.1 million and 31.0% respectively in Q3 2024[9] - Operating income for Q3 2025 was $47.6 million, resulting in an operating margin of 7.5%, compared to $22.3 million and 3.2% respectively in Q3 2024[9] - Net income for Q3 2025 was $29.3 million, or $0.76 per share, compared to $7.0 million, or $0.18 per share in Q3 2024[9] - Adjusted EBITDA for Q3 2025 was $57.5 million, with an adjusted EBITDA margin of 9.1%, compared to $73.9 million and 10.7% respectively in Q3 2024[9] Segment Performance - Nurse & Allied Solutions revenue was $361 million in Q3 2025, a 9.5% decrease year-over-year[9] - Physician & Leadership Solutions revenue was $175 million in Q3 2025, a 1.3% decrease year-over-year[9] - Technology & Workforce Solutions revenue was $95 million in Q3 2025, an 11.8% decrease year-over-year[9] Balance Sheet and Cash Flow - Cash and cash equivalents totaled $53 million as of September 30, 2025, compared to $42 million as of June 30, 2025[35] - Net cash provided by operating activities was $23 million in Q3 2025, compared to $67 million in Q3 2024[37] - Free cash flow was $15 million in Q3 2025, compared to $47 million in Q3 2024[37] Q4 2025 Financial Guidance - Consolidated revenue is projected to be between $715 million and $730 million[39] - Gross margin is expected to be between 25.5% and 26.0%[39] - Adjusted EBITDA margin is projected to be between 6.8% and 7.3%[39]